Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INNOVATE (VATE) Net Income: 2009-2025

Historic Net Income for INNOVATE (VATE) over the last 17 years, with Sep 2025 value amounting to -$9.6 million.

  • INNOVATE's Net Income rose 40.74% to -$9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$73.7 million, marking a year-over-year decrease of 123.33%. This contributed to the annual value of -$39.7 million for FY2024, which is 2.06% down from last year.
  • As of Q3 2025, INNOVATE's Net Income stood at -$9.6 million, which was up 54.29% from -$21.0 million recorded in Q2 2025.
  • In the past 5 years, INNOVATE's Net Income registered a high of $51.9 million during Q1 2021, and its lowest value of -$200.3 million during Q3 2021.
  • For the 3-year period, INNOVATE's Net Income averaged around -$12.3 million, with its median value being -$11.7 million (2023).
  • As far as peak fluctuations go, INNOVATE's Net Income plummeted by 2,542.68% in 2021, and later skyrocketed by 218.80% in 2024.
  • Quarterly analysis of 5 years shows INNOVATE's Net Income stood at -$5.5 million in 2021, then plummeted by 32.73% to -$7.3 million in 2022, then slumped by 45.21% to -$10.6 million in 2023, then crashed by 63.21% to -$17.3 million in 2024, then surged by 40.74% to -$9.6 million in 2025.
  • Its Net Income stands at -$9.6 million for Q3 2025, versus -$21.0 million for Q2 2025 and -$25.8 million for Q1 2025.